Article Information
History
- July 3, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Gayathri Delanerolle1,
- Jintong Hu*,2,
- Heitor Cavalini*,4,
- Lucy Yardley*,3,
- Katharine Barnard-Kelly4,
- Katheryn Elliot4,
- Vanessa Raymont5,
- Shanaya Rathod4,
- Jian Qing Shi**,2,4,6 and
- Peter Phiri**,3,4,†
- 1Nuffield Department of Primary Care Health Sciences, University of Oxford, OX3 7JX, Oxford, UK
- 2Southern University of Science and Technology, Shenzhen, 518055, China
- 3Psychology Department, Faculty of Environmental and Life Sciences, University of Southampton, SO17 1BJ, Southampton, UK
- 4Southern Health NHS Foundation Trust, SO40 2RZ, UK
- 5Department of Psychiatry, University of Oxford, OX3 7JX, Oxford, UK
- 6The Alan Turing Institute, NW1 2DB, London, UK
- ↵†Corresponding author: Dr Peter Phiri, BSc, PhD, RN, Director of Research & Innovation/ Visiting Fellow,
Research & Innovation Department, Southern Health NHS Foundation Trust, Clinical Trials Facility, Tom Rudd Unit Moorgreen Hospital, Botley Road, West End, Southampton SO30 3JB, United Kingdom, peter.phiri{at}southernhealth.nhs.uk
Author contributions GD and PP developed the study protocol and embedded this within the EPIC project’s work-package 3. The Chief Investigator of this study is PP and Principal Investigator GD. GD, JT and JQS designed and completed the statistical analysis. The qualitative analysis was completed by KBK, PP and GD. All authors critically appraised and commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Posted July 03, 2022.
Impact of SARS-Cov-2 on Clinical Trial Unit workforce in the United Kingdom; An observational study
